112
Do we tell our patients the truth about numbness after
orthognathic surgery?
L. Rennie
∗
, H. Barry, J. Collyer, K. Sneddon
Queen Victoria Hospital, East Grinstead, United Kingdom
Background:
The incidence of neurosensory deficit or damage to
the inferior dental nerve following mandibular osteotomies varies
widely within the literature. Objective testing figures are often
discussed with patients before surgery, however patient reported
feedback is less frequently discussed.
Objectives:
Determine the incidence of permanent neurosensory
deficit in patients under going bilateral sagittal split osteotomies,
compare the objective findings with patient perceived deficit and
address the effect of deficit on daily living.
Methods:
Patients undergoing bilateral sagittal split osteotomy
procedures were assessed with two-point discrimination preoper-
atively and then again at two-years postsurgery. Those assessed
to have a two-point discrimination score score
≥
3 mm were
regarded as presenting with measurable neurosensory deficit. At
the two-year review patients completed a questionnaire addressing
perceived numbness and its impact on daily living.
Findings and Conclusion:
78 patients were examined and 32%of
patients were found to have objective neurosensory deficit from
the two-point discrimination testing. 71% of patients, however,
reported a perceived numbness. Of these, 70.9% of patients stated
it “did not affect them” at all. Only 7% of patients with perceived
numbness stated it affected their lives “a lot”. Overall 96.2%would
recommend the surgery again.
Patient perception of numbness is perhaps a more important
measure than objective testing especially considering the dispar-
ity between objective and subjective measures. We can however
inform patients that most of those that perceive numbness do not
find it impacts heavily on their lives and almost all would still
recommend surgery.
http://dx.doi.org/10.1016/j.ijom.2017.02.394Effect of hand gesturing on difficulty with deep intravenous
anaesthesia
E. Roginsky Jr.
Sacred Heart Hospital, Allentown, PA, United States
Background:
During deep intravenous sedation some patients
exhibited hand gesturing; adduction of thumb third and fourth fin-
ger and pointing of the first and second finger, with no tremor
evident. We noted this seemed to accompany anxious or uncoop-
erative anaesthetic cases.
Objectives:
Identify hand gesturing and explore possible connec-
tion with sedation difficulty.
Methods:
Gesturing cases noted and data collected. Precise
description of hand gesturing was used to alert staff to its appear-
ance and enlist their help in recognising it. Photographs were taken
when possible.
Results:
One operator; 680 patients treated; 43 clinical sessions;
12 patients (1.76%) with gesturing. Of these, nine showed anx-
ious, uncooperative or even combative behaviour, while three did
not. Control was 23 patients (3.38%) without gesturing but with
uncooperative behaviour. Patients received varying dosages of
midazolam, fentanyl, ketamine and propofol. One patient with
gesturing received no ketamine.
Findings:
12 patients showed gesturing, nine of them (67%) were
uncooperative during sedation, compared to 23 out of 668 (3.6%)
uncooperative with no gesturing.
Conclusions:
Gesturing may be marker for anxiety during anaes-
thesia. Despite similar appearance to Parkinson resting tremor, I
found no description of static hand gesturing in the literature as it
relates to sedation or anaesthesia. A questionnaire and long-term
follow-up should be used to identify any connection to substance
abuse or neurologic conditions.
http://dx.doi.org/10.1016/j.ijom.2017.02.395Esmolol in outpatient oral surgery intravenous deep sedation
E. Roginsky Jr.
Sacred Heart Hospital, Allentown, PA, United States
Background:
Use of short acting beta-adrenergic antagonist
esmolol is a useful adjunct in maxillofacial surgery during general
anaesthesia.
Objective:
To demonstrate safety and effectiveness of esmolol in
outpatient intravenous deep sedation.
Methods:
Cases where esmolol was used for treating tachycardia
or hypertension in outpatient oral and maxillofacial surgery office.
Data collected concurrently with treatment.
Results:
One operator; 2950 patients treated; total of 14 months;
37 patients were given esmolol for clinically significant eleva-
tions in systolic blood pressure (SBP), diastolic blood pressure
(DBP) or heart rate (HR). The average ‘peak’ SBP, DBP and HR
when esmolol was given was 174.9 mm Hg, 105.7 mm Hg and
121.1 bpm, respectively (highest SBP, DBP and HR in study was
221 mm Hg, 130 mm Hg and 168 bpm, respectively). Average
baseline SBP, DBP and HR were 135.4 mm Hg, 86.0 mm Hg and
88.6 bpm, respectively. Average post-treatment SBP, DBP and
HR were 156.2 mm Hg, 100.0 mm Hg and 102.3 bpm, respec-
tively. Average esmolol dosage was 15.0 mg; (range, 5–40 mg).
Average medication dosages were: midazolam 3.93 mg, fentanyl
0.048 mg, ketamine 33.45 mg, propofol 44.86 mg and glycopyrro-
late 0.97 mg.
Conclusions:
Esmolol was safe and effective. Benefits include not
needing to cancel cases due to hypertension, uncontrolled rapid
HR (one patient had HR of 168 bpm) or haemorrhage. Treatment
was well-received (two patients were below 14 years old and one
had asthma). This suggests expanded and more routine use of
esmolol not only for haemodynamics but also to reduce nausea
and opioid requirement
. 1Reference
Harless, M., Depp, C., Collins, S., & Hewer, I. (2015). Role of esmolol in
perioperative analgesia and anesthesia: a literature review.
AANA J
,
83
,
167–177.
http://dx.doi.org/10.1016/j.ijom.2017.02.396




